Yousif Capital Management’s Coherus Oncology CHRS Stock Holding History

Yousif Capital Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,304	Closed	-$151K	–	1984
2023 Q2	$151K	Sell	35,304 -1,554	-4%	-$9.17K	﹤0.01%	1876
2023 Q1	$252K	Sell	36,858 -3,990	-10%	-$31K	﹤0.01%	1756
2022 Q4	$324K	Sell	40,848 -11,155	-21%	-$85.8K	﹤0.01%	1679
2022 Q3	$500K	Sell	52,003 -1,084	-2%	-$11K	0.01%	1510
2022 Q2	$384K	Sell	53,087 -4,040	-7%	-$35.1K	0.01%	1650
2022 Q1	$738K	Sell	57,127 -1,720	-3%	-$21.9K	0.01%	1476
2021 Q4	$939K	Buy	+58,847	New	+$1.03M	0.01%	1401

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Yousif Capital Management's CHRS Position: Q3 2023 in Review

Yousif Capital Management sold out of Coherus Oncology (CHRS) in Q3 2023, closing a stake of 35,304 shares — an estimated $151K sold.

Yousif Capital Management first reported a position in CHRS in Q4 2021 and held it in 7 quarters. The position peaked at $939K in Q4 2021. 169 funds tracked by Wall St. Rank hold CHRS as of Q3 2023.

Yousif Capital Management reported no remaining Coherus Oncology position as of Q3 2023 after selling out during the quarter.
Yousif Capital Management sold 35,304 Coherus Oncology shares in Q3 2023, an estimated $151K.
Yousif Capital Management first reported a position in Coherus Oncology in Q4 2021 and held it in 7 quarters.
Yousif Capital Management's Coherus Oncology position peaked at $939K in Q4 2021.
169 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2023.

Based on Yousif Capital Management's 13F filing for Q3 2023, filed 30 Oct 2023.